| Tag | Content |
|---|
EnhancerAtlas ID | HS056-09586 |
Organism | Homo sapiens |
Tissue/cell | GC_B_cell |
Coordinate | chr20:1830700-1832720 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| POU2F2 | MA0507.1 | chr20:1831472-1831485 | CACATTTGCATAT | + | 6.64 | | ZNF263 | MA0528.1 | chr20:1830718-1830739 | GGAGGTGGGGAAGGAGGATGG | + | 6.51 | | ZNF263 | MA0528.1 | chr20:1830715-1830736 | TGGGGAGGTGGGGAAGGAGGA | + | 6.66 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09273 | chr20:1830539-1835050 | CD14 | | SE_54036 | chr20:1830713-1832498 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr20 | 1830820 | 1832200 | | chr20 | 1832200 | 1832303 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH20I001850 | chr20 | 1830820 | 1832474 |
|
Enhancer Sequence | GGGTGGGGTA GGGGGTGGGG AGGTGGGGAA GGAGGATGGG GTTGGTTATC AGGTTCTCGT 60
CCTGAATGGC TCTGCCTCTG GCTTTCCCTG TAGCTTGGGC AGATGCCTTC TCTCGGGACC 120
TCAGTTTTCA CATCTGTGAA ATGTGGCAAT AGGGCCAAGT TGTCAGTGAC ATTCTTCCCA 180
GATGTCTCCC AAGTGTCAGG GCTGGATTTA TAAGCACCTA CTCAGTGCCA GGCCCTCTGT 240
GTTGTCCTGG AGAAAGAGAT GAATAAGACA CTTAACCCTG CCCTCCAGGA AGCCATGGAC 300
TAAAGGTGAA GGGAGTGTGG TGTGTGTGTG CGTGTGTGTG TGTGTGTGTG TGTGTGTGTG 360
TGTGTGTGTG TGTTGCATGT AGGCAACTGG GGATGAAAAA ATCAGTTTTA ACCTGTCACC 420
CAGCTGAGGC TCTCTAGGCT ACTTGGAGCT TCCTGGAATT TCCTTTGTGT CTAATTGCAA 480
TTAGCATTCT TTCCTGTCTA GTAGATGCAA TGTGTCCCTC GGGAGGAAAC GCAGAGACCA 540
CTGCGGAGAT GTTCCAGGAA CTGAAACCTT TGCCTTCCCT TTAGACTTGC CTCCTAACTC 600
CGTCTACATT AACCATATGT CTAATCTCAA GTCAAAAATT CAAGGTTTAT AGGGTAGGGG 660
CTAGGCTTGT CAGCATTTCC CAATGATGTC CTGTCCCACG ATAAAACAAT TCTGGGGACA 720
ATACATTCTG GAAATGCTAC ATGAAATCTC CCCCTCTTGA AGCTTCACAT TACACATTTG 780
CATATAGAAG AATCTAAGGG AAGCAAAAAA AAAAAAGTTT GTCAAACTTT GCTTAATCCA 840
GTTCTTCAAA CTTATTTAAC CACATAACTC TTTTTCTCAA AGTTCCTGTT TGCATCTCTG 900
TCAGTTATCA TGCTTTAACT TGCATCAGAA ACCTCAGTCA AGCTGGTTTA TGCAACCGGA 960
AGAGTACATT AGCTTTTGAG ACTGAAAGTC TAGAAAACAT AAGGGCCTCA GGTAGAGTTC 1020
AATCAAGGCC TCGGCTCCAT CTCTTGAGGC TTCCCTTGTG TCTCTATCCC CCCTTCTGTA 1080
CACTCGTAAG CTTCATCCTC AGCCTGGTTT ACCCCATAAG AACAAAATAG CTGCAGCAGT 1140
TCTGGGCATC ATATTCAAGT ACCCCACTGC ACAAAGAAGA GGAGCCTTCT CTTTTCATTA 1200
CAGACTGGAT GTCCTTGCTG TATTTAGACC ATGTACTTAT CTCTGAGCCA ATCACTGGGC 1260
AAGAGAAATA AATGGGCATC AGCCAATGAG AGCTTACCCC TGGGATGAAA TCATAACATC 1320
TTCCACAAAG CCTATGACAA TGTCTTCCTT CTAGTAACAC ATATCCCAGT AATCTCAGCT 1380
ATCCCATCCC ATTCTTTGCT AAGGAAACTG ATTTGTGTCC ACAGCACTGG TGAGCCACTG 1440
ATCTCAAAGA GGGTAGGCCC CTAACATGAA CTCTGGGGGT GAATCTTGAT TGGTCCAAAG 1500
ATCATGGTAA CCTTATTTCT CTTCACCAAC GATTGGTTCA GAGATGGCCA TAGGACTTGG 1560
TTCTAGCTAA TGAGATGCAA GCATCTCCTG GGTGGGGCTT CTAGAAAAGC TTTTGTCTTC 1620
TGGTGCAAAA AATAGACTTA GATGGCATAT TCCTTTGCTC CTTCACCTTT CCTTCTTCTT 1680
CATACCTGGA ATGAGGATTT GATACCTGGA GGTGTGGCAG CCATCGTGGG ACCAAGAGGC 1740
AAAAACTGCA AGAATAAATG CCACAGTCCC AGAGACTGCA GAACAGAAAA ATAGAGCCCA 1800
AAGGCTAGAC AACATTGTTG GGCAGCTGTG CATAGTCTGG AATGCTATCT CTTGACATCT 1860
TATTATGAAA AATTGGATTG GAAATACATA TTTGTTTGAG CCAAAGACAT TCATTACTAA 1920
CTGACCAAAG CCAAGTCATT TTTTGTAAAA TAGGACTTGT GAGAGCCTTG AGACACAGCC 1980
TTGAAGACAC AGCTTGAGTA TCCTTGAATT CCAGATACTT 2020
|
